smallAccCompHo_0921.xslt
Company Registration No. 13123884 (England and Wales)
HEALOME THERAPEUTICS LTD
Financial Statements
for the Period from 01 February 2025 to 31 January 2026

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

CONTENTS PAGE
Company Information 2
Statement of Financial Position 3
Notes to the Accounts 4
- 1 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Company Information

Company Details
Company Number 13123884
Registered Office BIRMINGHAM RESEARCH PARK
97 VINCENT DRIVE
BIRMINGHAM
ENGLAND
B15 2SQ
Directors
Directors who held office during the period were:
ASTLE, Christopher John, Dr   
David BAILEY   
MATLOCK, Johnathan Vincent, Dr   
Andrew Percy James WEBB   
WILLIAMS, Richard Lee, Dr   
- 2 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Statement of Financial Position

12345678910
Notes 2026 2025
£ £
Fixed Assets
Tangible assets 5 - 276
Current Assets
Debtors due 49,679 -
Cash at bank and in hand 1,042,292 1,494
1,091,971 1,494
Creditors
Amount falling due within one year (202,424) (74,004)
Net Current Assets 889,547 (72,510)
Total Assets less current liabilities 889,547 (72,234)
Creditors due after more than one year (167,059) (166,059)
Net Assets 722,488 (238,293)
Capital and Reserves
Called up Share Capital 1,301 834
Share Premium Account 1,454,322 149,874
Retained earnings at end of year (733,135) (389,001)
Shareholder funds 722,488 (238,293)
For the year ending 31/01/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 31 October 2026
Richard Williams
Company Registration No. 13123884
- 3 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

1. Statutory Information
HEALOME THERAPEUTICS LTD is a private company, limited by shares, registered in England and Wales, registration number 13123884.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.
Presentation Currency
The accounts are presented in £ sterling.
- 4 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

Current Tax
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all material timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Tangible Fixed Asset Policy
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:IT EquipmentPlant and machinery etc. 3 years5 – 10 years
- 5 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

Deferred Tax
Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all material timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.
- 6 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2026 1
2025 1
4. Principal Activity
Healome Therapeutics Limited is a research and development company
- 7 -

HEALOME THERAPEUTICS LTD

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

5. Fixed Assets
Computer Equipment Total
Cost or valuation £ £
At 01/02/2025 3,541 3,541
Additions - -
At 31/01/2026 3,541 3,541
Depreciation
At 01/02/2025 3,265 3,265
Charge for the year 276 276
At 31/01/2026 3,541 3,541
Net Book Value
At 31/01/2026 - -
At 31/01/2025 276 276
- 8 -